Preventive Cardiovascular Nurses Association
PCNA Login
Preventing Cardiovascular Disease
through continuing education, clinical tools and national health initiatives.
The current state of healthcare demands that nurses play a leading role in cardiovascular risk reduction.
Late Breaking News RSS newsfeed
- FDA approves expanded rosuvastatin label
- US clears wider use of AstraZeneca cholesterol drug - Reuters
- Less TV, More Family Dinners Fight Childhood Obesity - WebMD
- Repeatedly telling patients of their coronary disease risk improves outcomes
- Zero means nothing: "Gatekeeper" role of calcium scoring questioned
- From the heart: Call for better African CV research
- African Americans have highest risk of peripartum cardiomyopathy
- Journal Scan: Endothelial Function, Carotid-Femoral Stiffness, and Plasma Matrix Metalloproteinase-2 in Men With Bicuspid Aortic Valve and Dilated Aorta (J Am Coll Cardiol 2010;55:660-668.)
- Higher risk of AMI in women with gout
- Journal Scan: Distribution of 10-Year and Lifetime Predicted Risks for Cardiovascular Disease in US Adults: Findings From the National Health and Nutrition Examination Survey 2003 to 2006 (Circ Cardiovasc Qual Outcomes 2010;3:8-14.)
- Changes in diet and exercise can make a big difference within six months of ACS
- Thomas recalls SafeSheath CSG introducers
- A good report card for laser-assisted pacemaker/ICD lead extraction
- Statins fail to slow progression of small AAAs
- Religion, spirituality not associated with better cardiovascular health
- UK cardiologists petition NICE to reverse dronedarone decision
- Expert Opinion: Lipid Management in Patients with Diabetes: LDL Lowering, Then What?
- Stand up and be counted: ECG-based test for long-QT syndrome proposed
- Cardiologist may score "big" in Ohio whistleblower case
- Procedure volume is a close proxy for popular hospital quality rankings
- Asymptomatic Brugada patients may not need ICDs
- One in five kids with abnormal lipids
- Opportunity lost: 400 000 US CHD deaths predicted for 2010, as risk-reduction goals fall short
- Déjà vu? Experts debate new data on diuretic/CCB combo and MI risk
- New advisory warns of CV risk with common prostate-cancer treatment
- POPE published: Avoid NSAIDs for asymptomatic pericardial effusions
- No rebound effect with platelets after stopping clopidogrel
- Herbal heartache: New review reminds cardiologists to query supplement use
- CT more accurate than MRI for ruling out coronary artery disease
- No time like the present: Study supports early mitral-valve repair in asymptomatic patients
- Clinical Trial Summary: Randomized, Controlled Trial of the Medtronic Endeavor Drug-Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions (ENDEAVOR IV)
- Best timing of surgery for active mitral endocarditis remains controversial
- Ripe for change: US ponders populationwide salt-reduction policies
- OCT finds additional at-risk lesions in AMI patients
- The atrial septal poucha new source of thrombus?
- Looking after their own: Surgeons may provide better care than intensivists in ICU
- Beta blockers: Less effect on pulse pressure than diuretics
- ARBs, ACE inhibitors, and Alzheimer's
- Study finds delaying surgery after PCI prevents kidney injury
- Scared healthy? Not quite: Mixed results for changing behavior with imaging
- Weight loss important in BP management: ENCORE published
- New UK data support ACCORD findings, emphasize need for individualization of blood glucose control
- Now in 3D! Automated three-dimensional X-ray angiography shows promise in small trial
- Ablation bests antiarrhythmic drug therapy in recurrent paroxysmal AF: THERMACOOL AF
- BMJ feature story peers into MIST controversy
- Liraglutide approved for type 2 diabetes
- Society of Thoracic Surgeons' national database effort comes of age
- FDA clears percutaneous valve for RVOT conduit
- Serial natriuretic-peptide testing unmasks shifts in CV risk in the elderly
- How to get "clinically significant" randomized trials
- Same weight loss, better BP with low-carb diet vs drug/diet combo
- New variant linked to platelet response and bleeding events with clopidogrel
- Obesity by any measure linked to increased ischemic-stroke risk
- FDA adds contraindication to sibutramine; Europe moves to yank it altogether
- Prehospital ECG speeds STEMI patients' route to cath lab
- Red yeast rice comparable to pravastatin for statin-intolerant patients
- Canadian transcatheter-valve series offers insights into highest-risk patients
- Don't get greedy: Registry data support treating culprit lesion only in initial PCI for STEMI
- Mild emphysema tied to subclinical LV diastolic dysfunction in population-based study
- New data prompt renewed calls for public-health initiative to cut salt in US diet
- FDA approves Thoratec's HeartMate II LVAD for destination therapy
- EVAR beats open surgery for ruptured AAAs
- ADA exalts HbA1c for diabetes diagnosis, updates aspirin recommendations
- ED predicts future CVD but doesn't add beyond traditional risk factors
- Use of preventive medications declines rapidly after stroke
- Telomere length could explain effects of fish oil in CHD
- Acceptable primary-PCI delay time may depend on patient baseline risk
- A-bomb survivor data affirm radiation/CVD risk link
- Tailored statin approach targeting baseline risk best for preventing CAD
- ACE inhibitors, ARBs, and beta blockers reduce risk of AF
- DNA methylation observed for first time in heart failure
- Guidelines survey aims for flexible design of CV-risk screening programs
- Court declines to hear ACC Medicare payment lawsuit
- Japanese study finds CT plaque analysis predicts post-PCI myocardial injury
- TAVI has low acute renal injury rate, compares favorably with surgical valve replacement
- US healthcare reform bills inspire fear and hope in cardiologists
- Cardiac CT angiography points to preclinical atherosclerosis in HIV+ men
- Weekend stroke patients more likely to receive tPA
- Call for regional systems of care for out-of-hospital cardiac arrest
- PLATO-Invasive in print, with new data on stent thrombosis for ticagrelor
- Most Americans overweight, and one-third are obese: NHANES
- Cocaine-related sudden death not so rare
- Panel to FDA: Nebivolol shouldn't be approved for chronic heart failure
- Improving adherence better than lower thresholds for maximizing statin benefits
- First look at effects of resting heart rate and exercise on heart-disease deaths
- New gene variants associated with heart rate, ECG measures, and AF
- COMPARE in print, shows everolimus stent advantage over paclitaxel
- Prasugrel "economically attractive" treatment based on cost-effectiveness analysis
- Additional rest SPECT test found unnecessary in patients with normal stress SPECT
- FDA will argue against nebivolol approval for HF
- Recommended lipid, glucose monitoring underused in patients taking antipsychotics
- ASTRONOMER published: No role for statins in aortic stenosis
- Could vitamin-D deficiency account for higher CV mortality in blacks?
- Varenicline safe and effective in cardiovascular disease
- Obesity overtakes smoking as health burden in US
- Quitting smoking ups short-term risk of type 2 diabetes in ARIC analysis
- Case Study: A 42-Year-Old African-American Male Presents With Increasing Body Weight, Type 2 Diabetes, Elevated BP, and a Long History of Schizophrenia
- ARREST finds link between chest compressions and VF recurrence during CPR
- Overweight, obesity up CV risk regardless of metabolic markers in long-term study
- Maternal benefits of breast-feeding: Less risk of vascular disease
- VTACH: Ablation before ICD reduces recurrence of ventricular tachycardia
- A year to remember: AHA picks top 10 studies for 2009
- ACC sues HHS over planned reimbursement cuts
- NICE leans away from dronedarone for atrial fib
- Studies show cardiovascular devices often earn FDA approval without high-quality clinical data
- ACS predominates among cardiovascular emergencies on cruises
- One in five heart-transplant patients get skin cancer within five years
- Antidepressant use increases all-cause mortality, stroke in postmenopausal women
- New data for second-generation DES should reassure doctors on safety, efficacy, even for off-label use
- Guidance for cardiac patients considering high-altitude activities
- Strongest evidence yet that Lp(a) causes heart disease
- Myxo ring controversy makes front-page news in Wall Street Journal
- Optimal duration of dual antiplatelet therapy after DES: 12 months, but more data coming
- Pfizer licenses apoA-I Milano to the Medicines Company
- FDA says cancer risk with ezetimibe is unlikely
- Quality of HDL differs in diabetics but improves with niacin therapy
- Largest-ever meta-analysis finds CRP is unlikely to be causal for CVD
- Perseverance pays for older patients who start cardiac rehab
- Benefits of dispatcher-assisted CPR outweigh the risks
- Obesity survival effect may elude highest-BMI patients in preserved-EF heart failure
- AHA: Focus on cardiovascular health, not disease
- ERASE-MI: Initial results with elinogrela new IV/oral P2Y12 antiplatelet
- Coronary calcification progression doubted as a CV diagnostic
- Use of AF ablation continues to grow and includes tougher cases
- Thousands of new cancer diagnoses predicted, due to soaring use of CT
- One more thing to worry about: MRI may interfere with pacemaker pulses
- Celecoxib could impede effects of low-dose aspirin
- Survival with ICD in heart failure: "Real-world" experience on par with trials
- Intensive medical therapy in asymptomatic carotid stenosis helps reduce microemboli and CV risk
- Medicines Company recalls specific lots of CCB Cleviprex
- FDA advisory panel votes in favor of broadened rosuvastatin indication
- UK scientists unearth potential new biomarker for MI
- Darusentan disappoints in DORADO-AC; company to drop the drug
- Stay slim, active, smoke-free: Live long and free of CVD
- Treatment to low glucose targets cuts CV risk in less-sick diabetics: Cohort study
- High-dose statin therapy reduces recurrent cardiovascular events
- Computer simulation shows CT may be cost-effective option for chest pain
- Circadian disturbance: A contributor to hypertension?
- First randomized study of endovascular aortic repair offers more questions, few answers
- FDA panel readies to review expanded rosuvastatin label
- Adverse lipid changes seen during transition to menopause
- Smoking cessation confers survival benefits after first AMI
- Low-carb diets hit the headlines again
- Diet-related weight loss in obese improves cardiac structure, function
- PROTECT halted: Event rates fall by treating HF with natriuretic-peptide guidance
- Exercise in young obese children reduces BP, improves markers of atherosclerosis
Annual Symposium indexPCNA 3-day April Program on Cardiovascular Risk Reduction
PCNA 16th Annual Symposium - Call for Abstracts
April 15-17, 2010
Northwest Chicago, IL 